1-20 of 52
Authors: Maria Tsoli
Journal Article
Germline analysis of an international cohort of pediatric diffuse midline glioma patients
Neuro-Oncology, noaf061, https://doi.org/10.1093/neuonc/noaf061
Published: 12 March 2025
Journal Article
ACCEPTED MANUSCRIPT
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic
Neuro-Oncology, noaf035, https://doi.org/10.1093/neuonc/noaf035
Published: 12 February 2025
Journal Article
DIPG-76. PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.129
Published: 18 June 2024
Journal Article
DIPG-35. OVERCOMING THE BLOOD-BRAIN BARRIER CHALLENGE IN DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.088
Published: 18 June 2024
Journal Article
DIPG-24. COMBINED EPIGENETIC THERAPY WITH FACT AND BET INHIBITORS REMODELS CHROMATIN AND DISRUPTS ONCOGENIC TRANSCRIPTION IN DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.077
Published: 18 June 2024
Journal Article
MDB-61. STARVING TUMORS OF POLYAMINES: A NOVEL APPROACH IN TREATING AGGRESSIVE PEDIATRIC MEDULLOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.510
Published: 18 June 2024
Journal Article
DIPG-48. PRECISION GUIDED THERAPY PROVIDES CLINICAL BENEFIT IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.101
Published: 18 June 2024
Journal Article
DIPG-46. TOTAL THERAPY FOR DIFFUSE MIDLINE GLIOMAS: A SEQUENTIAL, INTENSIVE, MULTI-AGENT COMBINATION PLATFORM IS A POTENT TREATMENT STRATEGY
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.099
Published: 18 June 2024
Journal Article
DIPG-50. TARGETING VULNERABILITIES IN PAEDIATRIC DIFFUSE MIDLINE GLIOMAS: LEVERAGING PLK1 INHIBITION TO EXPLOIT RAS/PI3K PATHWAY DEPENDENCY
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.103
Published: 18 June 2024
Journal Article
DIPG-16. THE BIG AND SMALL OF PROTEIN POST-TRANSLATIONAL MODIFICATIONS: TARGETING SUMOYLATION AND CITRULLINATION IN DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.069
Published: 18 June 2024
Journal Article
DDEL-07. BARRIER TO PROGRESS: DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) INDUCES A TIGHTENED BLOOD-BRAIN BARRIER PHENOTYPE
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v102–v103, https://doi.org/10.1093/neuonc/noad179.0386
Published: 10 November 2023
Journal Article
DDDR-30. IDENTIFICATION OF DRIVERS OF RESISTANCE IN BRAFV600E PEDIATRIC HIGH-GRADE GLIOMA AND NOVEL THERAPEUTIC TARGETS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v112, https://doi.org/10.1093/neuonc/noad179.0423
Published: 10 November 2023
Journal Article
EXTH-31. EXPLOITING THE GENETIC DEPENDENCY ON PI3K/MTOR SIGNALING FOR THE TREATMENT OF H3-ALTERED DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v230–v231, https://doi.org/10.1093/neuonc/noad179.0884
Published: 10 November 2023
Journal Article
DIPG-29. A CONNECT CONSORTIUM PRECLINICAL STUDY IDENTIFIES MEK INHIBITION AND RADIATION AS POTENTIAL COMBINATION PARTNERS FOR THE ALK2 INHIBITOR TP-0184 IN ACVR1-MUTANT DMG
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i19, https://doi.org/10.1093/neuonc/noad073.076
Published: 12 June 2023
Journal Article
DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i17, https://doi.org/10.1093/neuonc/noad073.067
Published: 12 June 2023
Journal Article
DIPG-21. DIPG cells alter the permeability of the blood-brain barrier in the brainstem leading to treatment failure.
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i22, https://doi.org/10.1093/neuonc/noac079.078
Published: 03 June 2022
Journal Article
DIPG-20. Copper chelation therapy targets S-adenosylmethionine (SAM) metabolism and epigenetic regulators in diffuse intrinsic pontine glioma (DIPG)
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i22, https://doi.org/10.1093/neuonc/noac079.077
Published: 03 June 2022
Journal Article
DIPG-08. The development of ACT001 as a novel therapeutic for diffuse intrinsic pontine gliomas
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i19, https://doi.org/10.1093/neuonc/noac079.065
Published: 03 June 2022
Journal Article
DIPG-37. Exploring the role of the epigenetic factor H2A.Z acetylation in DIPG
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i26–i27, https://doi.org/10.1093/neuonc/noac079.094
Published: 03 June 2022
Journal Article
DIPG-19. FOXR2 is an oncogenic driver across pediatric and adult cancers
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i21–i22, https://doi.org/10.1093/neuonc/noac079.076
Published: 03 June 2022
